Latest News

Johnson & Johnson confirms opioid business has ended in $230 million settlement with New York


Johnson & Johnson has agreed to halt sales of opioids nationwide in a $230 million settlement with New York state.

Taiwan reports first domestic case of Delta Covid variant

Previous article

Inflation looks bad now, but it’s pretty much sticking to the script

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News